Product Information
HADLIMA PUSHTOUCH 40 MG/0.8 ML is a brand biologic product labeled by Organon LLC, priced at $623.4931 per ML under NDC 78206018401. Its NADAC has been published 76 times since Apr 23, 2025.
Strength
40 mg/.8mL
Manufacturer
Organon LLCNDC
78206018401
Classification
Brand Biologic
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ADALIMUMABApproval Type
Biologic (BLA)
FDA Application
BLA761059On Market Since
7/1/2023
Pharmacological Classes
Price Statistics
The NADAC for HADLIMA PUSHTOUCH 40 MG/0.8 ML has been published 76 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $623.4931 per ML |
|---|---|
| All-time high | $634.4750 (Jul 15, 2026) |
| All-time low | $622.7586 (Jul 22, 2026) |
| 52-week high | $634.4750 |
| 52-week low | $622.7586 |
| Median price | $630.5475 |
| Average price | $630.1097 |
| Largest weekly change | -1.8% (Jul 22, 2026) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
adalimumab-bwwd market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tumor Necrosis Factor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HADLIMA PUSHTOUCH 40 MG/0.8 ML?
The current National Average Drug Acquisition Cost (NADAC) for HADLIMA PUSHTOUCH 40 MG/0.8 ML, manufactured by Organon LLC, is $623.4931 per ML (NDC 78206018401), effective Sep 30, 2026.
How has the price of HADLIMA PUSHTOUCH 40 MG/0.8 ML changed over time?
Over the history we have for it, the NADAC for HADLIMA PUSHTOUCH 40 MG/0.8 ML has held within roughly two percent of its current level. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for HADLIMA PUSHTOUCH 40 MG/0.8 ML?
Since Apr 23, 2025, the NADAC for HADLIMA PUSHTOUCH 40 MG/0.8 ML has ranged from a low of $622.7586 (Jul 22, 2026) to a high of $634.4750 (Jul 15, 2026), with a median of $630.5475 per ML.
Are there cheaper alternatives to HADLIMA PUSHTOUCH 40 MG/0.8 ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HADLIMA PUSHTOUCH 40 MG/0.8 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures HADLIMA PUSHTOUCH 40 MG/0.8 ML?
HADLIMA PUSHTOUCH 40 MG/0.8 ML (NDC 78206018401) is labeled by Organon LLC, and CMS classifies it as a brand biologic product.